These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 9748122)

  • 1. Differential uptake of estramustine phosphate metabolites and its correlation with the levels of estramustine binding protein in prostate tumor tissue.
    Walz PH; Björk P; Gunnarsson PO; Edman K; Hartley-Asp B
    Clin Cancer Res; 1998 Sep; 4(9):2079-84. PubMed ID: 9748122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uptake and retention of estramustine and the presence of estramustine binding protein in malignant brain tumours in humans.
    Bergenheim AT; Gunnarsson PO; Edman K; von Schoultz E; Hariz MI; Henriksson R
    Br J Cancer; 1993 Feb; 67(2):358-61. PubMed ID: 8431366
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Partial characterization and "quantitation" of a human prostatic estramustine-binding protein.
    Björk P; Forsgren B; Gustafsson JA; Pousette A; Högberg B
    Cancer Res; 1982 May; 42(5):1935-42. PubMed ID: 7066904
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Pharmacology and metabolism of a new therapeutic drug for prostatic cancer "Estracyt"].
    Yamanaka H; Shida K
    Gan To Kagaku Ryoho; 1984 Mar; 11(3):537-44. PubMed ID: 6422861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estramustine-binding protein and specific binding of the anti-mitotic compound estramustine in astrocytoma.
    Bergenheim AT; Björk P; Bergh J; von Schoultz E; Svedberg H; Henriksson R
    Cancer Res; 1994 Sep; 54(18):4974-9. PubMed ID: 8069865
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and partial characterization of estramustine-binding protein (EMBP) in human breast cancer and malignant melanoma.
    Björk P; Borg A; Fernö M; Nilsson S
    Anticancer Res; 1991; 11(3):1173-82. PubMed ID: 1888147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Estracyt (estradiol-nitrogen mustard complex)--estramustine binding protein and its specificity].
    Yamanaka H; Imai K; Suzuki T; Yuasa H; Takahashi E
    Gan To Kagaku Ryoho; 1984 Oct; 11(10):2106-14. PubMed ID: 6486830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estramustine-binding protein (EMBP) content in four different cell lines and its correlation to estramustine induced metaphase arrest.
    Eklöv S; Mahdy E; Wester K; Björk P; Malmström PU; Busch C; Nilsson S
    Anticancer Res; 1996; 16(4A):1819-22. PubMed ID: 8712706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uptake of estramustine phosphate (estracyt) metabolites in prostatic cancer.
    Norlén BJ; Andersson SB; Björk P; Gunnarsson PO; Fritjofsson A
    J Urol; 1988 Nov; 140(5):1058-62. PubMed ID: 3172360
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Estramustine binding protein (EMBP) in rat R3327 Dunning tumors: partial characterization and effect of hormonal withdrawal, hormonal replacement, and cytotoxic treatment on its expression.
    Björk P; Isaacs JT; Hartley-Asp B
    Prostate; 1991; 18(3):181-200. PubMed ID: 2020618
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical study on estramustine binding protein (EMBP) in human prostate.
    Shiina H; Igawa M; Ishibe T
    Prostate; 1996 Sep; 29(3):169-76. PubMed ID: 8827085
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dose escalation study of intravenous estramustine phosphate in combination with Paclitaxel and Carboplatin in patients with advanced prostate cancer.
    Kelly WK; Zhu AX; Scher H; Curley T; Fallon M; Slovin S; Schwartz L; Larson S; Tong W; Hartley-Asp B; Pellizzoni C; Rocchetti M
    Clin Cancer Res; 2003 Jun; 9(6):2098-107. PubMed ID: 12796374
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estramustine-binding protein--a marker for effect of therapy in prostatic carcinoma?
    Björk PA; Flüchter SH; Nelde HJ
    Scand J Urol Nephrol Suppl; 1988; 107():59-64. PubMed ID: 3287599
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distribution of estramustine in the BT4C rat glioma model.
    Johansson M; Bergenheim AT; D'Argy R; Edman K; Gunnarsson PO; Widmark A; Henriksson R
    Cancer Chemother Pharmacol; 1998; 41(4):317-25. PubMed ID: 9488601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dramatic decline in prostate-specific antigen by withdrawal of estramustine phosphate in hormone refractory prostate cancer.
    Kobayashi M; Kuramoto H; Ota J; Fujimoto N
    Int J Urol; 2006 Jul; 13(7):1019-21. PubMed ID: 16882080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Apoptotic tumor cell death induced by estramustine in patients with malignant glioma.
    Vallbo C; Bergenheim AT; Bergström P; Gunnarsson PO; Henriksson R
    Clin Cancer Res; 1998 Jan; 4(1):87-91. PubMed ID: 9516956
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estramustine binding protein in human brain-tumor tissue.
    von Schoultz E; Bergenheim T; Grankvist K; Henriksson R
    J Neurosurg; 1991 Jun; 74(6):962-4. PubMed ID: 1709687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer; plasma concentrations of estramustine phosphate and its metabolites.
    Kirdani RY; Karr JP; Murphy GP; Sandberg AA
    N Y State J Med; 1980 Aug; 80(9):1390-3. PubMed ID: 6938806
    [No Abstract]   [Full Text] [Related]  

  • 19. Estramustine-binding protein in carcinoma and benign hyperplasia of the human prostate.
    Shiina H; Urakami S; Shirakawa H; Igawa M; Ishibe T; Usui T
    Eur Urol; 1996; 29(1):106-10. PubMed ID: 8821700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Binding sites for the cytotoxic metabolites of estramustine phosphate (Estracyt) in rat and human pancreas that are distinct from pancreatic estrogen-binding protein.
    Björk P; Jönsson U; Andrén-Sandberg A
    Pancreas; 1991 Jan; 6(1):77-89. PubMed ID: 1994382
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.